AuroBlog - Aurous Healthcare Clinical Trials blog
AUGUST 7, 2022
Imagine you’ve just completed a tough upper-body workout. Your muscles feel a bit tired, but all in all, you’re able to go about the rest of your day just fine. The next morning, you wake up and realize the back of your shoulder blade feels stiff. When you rub your shoulder muscles, it feels like […].
NPR Health - Shots
AUGUST 7, 2022
Africa's metalheads have a bold vision. We talk to Edward Banchs, author of a new book about Africa's metal scene, and to a heavy metal singer in Botswana known as "Vulture.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuroBlog - Aurous Healthcare Clinical Trials blog
AUGUST 7, 2022
The Association of Indian Medical Device Industry (AiMeD) has urged Prime Minister Narendra Modi to either change the name of Department of Pharmaceuticals to Department of Pharmaceuticals & Medical Devices or set up a Separate Department of Medical Devices. In a letter, AiMeD on behalf of the Indian Medical Devices industry urged the PM to […].
STAT News
AUGUST 7, 2022
A clinical trial run by Amgen that combined its KRAS-targeting cancer drug called Lumakras with other immunotherapies caused serious liver side effects — forcing lung cancer patients to abandon treatment and leading to substantially lower tumor response rates. The study results, presented Sunday at a lung cancer meeting in Vienna, are a setback for Amgen’s effort to craft new treatments involving Lumakras.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
NPR Health - Shots
AUGUST 7, 2022
Hong Kong's COVID lockdown measures have devastated the city's tourism industry and disrupted business travel in a city known for being an international financial center and a business hub.
Drug Patent Watch
AUGUST 7, 2022
Annual Drug Patent Expirations for IXEMPRA+KIT Ixempra Kit is a drug marketed by R-pharm Us Llc and is included in one NDA. It is available from one supplier. There are…. The post New patent expiration for R-pharm Us drug IXEMPRA KIT appeared first on DrugPatentWatch - Make Better Decisions.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
World of DTC Marketing
AUGUST 7, 2022
According to a 2021 study , 1.1 million deaths—including one in two of those under 65, thanks in large part to our abysmal health care system—”would have been averted if the U.S. had the mortality rates of other wealthy nations. One in three GoFundMe campaigns is now for healthcare-related costs, and it’s getting worse. The passage of the Inflation Control bill is an excellent first step in limiting high drug costs, but our healthcare system is still built for profit at the expense
Drug Patent Watch
AUGUST 7, 2022
Pharmaceutical drug patents enable branded drug companies to prevent market entry by competitors until the patents expire. The term of drug patents varies. The basic term for a patent is…. The post Future drug patent expirations by year appeared first on DrugPatentWatch - Make Better Decisions.
STAT News
AUGUST 7, 2022
WASHINGTON — Democrats’ high hopes to lower insulin costs for patients with insurance got downsized on Sunday, and now only Medicare patients will see relief at the pharmacy counter. Back in November, the party had grand ambitions of capping insulin costs at $35 per month for all patients with insurance. But when they tried to insert the policy into the sweeping climate, tax, and health care package they’re advancing this month, it conflicted with Senate rules.
STAT News
AUGUST 7, 2022
WASHINGTON — President Biden is on the verge of his own crowning health care achievement to call, in his words, a BFD. After two decades, Democrats are finally on track to break the firewall between the pharmaceutical industry and the Medicare program. Soon, the U.S. government will be able to use the full brunt of its leverage to negotiate discounts from drugmakers, like the governments in many other high-income countries.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Expert insights. Personalized for you.
180 
Let's personalize your content